9 hours Ago
Edesa Biotech ( NASDAQ: EDSA ) announced the appointment of Peter J. Weiler as chief financial officer, effective May 1, 2025. Weiler will succeed Stephen Lemieux.
Most recently, Weiler served as president of Exzell Pharma, a privately held, commercial-stage pharmaceutical company. Lemieux will continue to provide financial advisory services to Edesa. EDSA shares fall 4.
8% post-market on Friday. Source: Press release More on Edesa Biotech Edesa Biotech announces $15 million private placement Edesa Biotech shares jump on $15M private placement Seeking Alpha’s Quant Rating on Edesa Biotech Historical earnings data for Edesa Biotech Financial information for Edesa Biotech.
